Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 2
2005 2
2006 8
2007 11
2008 10
2009 12
2010 17
2011 18
2012 22
2013 13
2014 23
2015 24
2016 16
2017 10
2018 22
2019 21
2020 13
2021 28
2022 24
2023 16
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

260 results

Results by year

Filters applied: . Clear all
Page 1
Impact of filgotinib on pain control in the phase 3 FINCH studies.
Taylor PC, Kavanaugh A, Nash P, Pope J, Pongratz G, Fautrel B, Alten R, Hasegawa K, Rao S, de Vries D, Stiers PJ, Watson C, Westhovens R. Taylor PC, et al. Among authors: westhovens r. RMD Open. 2024 Mar 12;10(1):e003839. doi: 10.1136/rmdopen-2023-003839. RMD Open. 2024. PMID: 38479751 Free PMC article.
To flare or not to flare: patients' and rheumatologists' perceptions on the on-flare retreatment strategy of rituximab in rheumatoid arthritis.
Bertrand D, Deprez A, Doumen M, De Cock D, Pazmino S, Marchal A, Thelissen M, Joly J, De Meyst E, Neerinckx B, Westhovens R, Verschueren P. Bertrand D, et al. Among authors: westhovens r. Ther Adv Musculoskelet Dis. 2024 Feb 28;16:1759720X241232268. doi: 10.1177/1759720X241232268. eCollection 2024. Ther Adv Musculoskelet Dis. 2024. PMID: 38425577 Free PMC article.
EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis.
Parodis I, Girard-Guyonvarc'h C, Arnaud L, Distler O, Domján A, Van den Ende CHM, Fligelstone K, Kocher A, Larosa M, Lau M, Mitropoulos A, Ndosi M, Poole JL, Redmond A, Ritschl V, Alexanderson H, Sjöberg Y, von Perner G, Uhlig T, Varju C, Vriezekolk JE, Welin E, Westhovens R, Stamm TA, Boström C. Parodis I, et al. Among authors: westhovens r. Ann Rheum Dis. 2023 Aug 23:ard-2023-224416. doi: 10.1136/ard-2023-224416. Online ahead of print. Ann Rheum Dis. 2023. PMID: 37433575
Effects of filgotinib on semen parameters and sex hormones in male patients with inflammatory diseases: results from the phase 2, randomised, double-blind, placebo-controlled MANTA and MANTA-RAy studies.
Reinisch W, Hellstrom W, Dolhain RJEM, Sikka S, Westhovens R, Mehta R, Ritter T, Seidler U, Golovchenko O, Simanenkov V, Garmish O, Jeka S, Moravcová R, Rajendran V, Le Brun FO, Arterburn S, Watkins TR, Besuyen R, Vanderschueren D. Reinisch W, et al. Among authors: westhovens r. Ann Rheum Dis. 2023 Aug;82(8):1049-1058. doi: 10.1136/ard-2023-224017. Epub 2023 May 3. Ann Rheum Dis. 2023. PMID: 37137672 Free PMC article. Clinical Trial.
260 results